Scotiabank lowered the firm’s price target on Andlauer Healthcare (ANDHF) to C$43 from C$44.50 and keeps a Sector Perform rating on the shares.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ANDHF:
- Andlauer Healthcare Group Declares First Quarter Dividend
- Andlauer Healthcare Group Forms Joint Venture with NowPac
- Andlauer Healthcare price target raised to C$44.50 from C$44 at Scotiabank
- Andlauer Healthcare price target lowered to C$53 from C$54 at TD Securities
- Andlauer Healthcare Group Reports Stable 2024 Earnings